The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.

Slides:



Advertisements
Similar presentations
Monitoring the impact of vaccination on rubella and CRS Susan E. Reef, MD 11 th Annual Meeting The Measles and Rubella Initiative Sept. 19, 2012.
Advertisements

Global Measles and Rubella Strategic Plan
House-to-House Social mobilization for Measles/Rubella SIAs in Rwanda, March 2013 American Red Cross to RWANDA RED CROSS.
Measles elimination in the African Region- Regional updates
1 June 2011 Measles update- India Dr. Satish Kumar Gupta Health Specialist UNICEF- India 13 th September 2011.
Measles Outbreaks in Southern Africa in 2010 Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
World Health Organization Western Pacific Regional Office Expanded Programme on Immunization WHO Region for Western Pacific 10 th Annual Measles Initiative.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
Regional Progress Towards Measles and Rubella Elimination Tenth Annual Measles Initiative Meeting September 13-14, 2011 Washington, DC Sergei Deshevoi.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
Challenges in Measles Outbreak Responses MSF Perspectives Florence Fermon - Myriam Henkens 10th Annual Measles Initiative Meeting 14/09/2011.
Measles outbreak investigation & Response Jordan DR MOHAMAD RATIB SUROUR NATIONAL EPI MANAGER INTER-COUNTRY MEETING ON MEASLES AND RUBELLA CONTROL AND.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Comparing Rubella Vaccination Strategies in China Linda Q. Gao North Central College Herbert Hethcote The University of Iowa May 18, 2004 DIMACS.
Measles control and elimination in the Eastern Mediterranean Region
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Measles vaccination in MSF context: priorities, results and challenges/concerns AFRICAN REGIONAL MEASLES-RUBELLA TAG MEETING Nairobi, June 2nd-3rd 2015.
1 AFRO Measles TAG – Nairobi 2-3 June 2015 MCV2 Introduction and the Second Year of Life Contact Lessons and way forward Raoul KAMADJEU UNICEF ESARO Meeting.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
1 | Global Immunization Meeting: PIA Sitges, June 2015 New tools and strategies for maternal and neonatal tetanus and measles/rubella elimination.
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Progress in the Elimination of Measles, Rubella and Congenital Rubella Syndrome in the Americas XV DbI Conference Sao Paulo, September 27th, 2011 Dr. Salvador.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
Palestine Bahrain Global Measles and Rubella Management Meeting Boubker Naouri March, 2011 Geneva, WHO HQ.
Update on Measles Mortality Reduction Activities and Linkages with RI.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
Measles elimination Dr. As’ad Ramlawi Palestine..
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
World Health Organization Eastern Mediterranean Region.
Funding Update: 2013 – 2015 September 10,
Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.
Regional measles elimination program updates B Masresha WHO AFRO AFR MR TAG Meeting Nairobi, June 2015.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
MR introduction and rubella epidemiology in AFRO Regional MR TAG Nairobi, Kenya June 2-3, 2015.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Gavi’s Measles and Rubella Programme:Update Stefano Malvolti September 2015, Washington DC Page: 1 Reach every child.
Measles Outbreak in Skopje, Republic of Macedonia, 2014 Erjona Shakjiri 1, D. Kochinski 1, Sh. Memeti 1, B. Aleksoski 1, K. Stavridis 1, V. Mikic 1, G.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
New Vaccine Introduction ‘MR vaccine introduction in Kenya’
PROGRESS TOWARDS MEASLES & RUBELLA ELIMINATION EXPERIENCE FROM OMAN SALAH AL AWAIDY, MD COMMUNICABLE DISEASES ADVISOR MOH, OMAN
Rubella Surveillance and Control in Low-Resource Settings: Limitations, Biases, and Potential for Strengthening Amy Winter, PhD Candidate, Princeton University.
Maternal and Neonatal Tetanus Elimination (MNTE) in Kenya Dr Collins Tabu, National Vaccines and Immunization Program Ministry of Health, Kenya.
Measles and Measles Outbreaks in China Accelerating Progress towards Measles/Rubella Control and Elimination Goals Meeting Geneva, Switzerland June 19,
Accelerating Progress towards Measles and Rubella Elimination WHO Western Pacific Region UNICEF East Asia and Pacific Region 1 21 June 2016 Geneva, Switzerland.
Accelerating Progress towards Measles and Rubella Elimination Eastern Mediterranean Region 1 21 June 2016 Geneva, Switzerland.
GAVI’S NEW MEASLES AND RUBELLA STRATEGY Dr. Khin Devi Aung Gavi Secretariat 21 June 2016, Geneva 1 #vaccineswork.
Global Measles and Rubella: Highlights, Priorities and Critical Issues
Session 4 Cross Cutting MR and RI Priorities Introduction
Global Overview of Measles
World Health Organization
Accelerating Progress towards Measles and Rubella Elimination
Progress and Challenges with achieving Universal Immunization Coverage
مراقبت بيماريهاي بثوري تب دار باهدف حذف سرخك و سرخجه
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
Stakeholder Consultation
African Region- priorities to reach the 2020 measles elimination goal.
Experience with the measles outbreak response fund
Maintaining Elimination in an Environment of Persistent Importation
YELLOW FEVER VACCINE AVAILABILITY AND NEEDS FOR THE AFRICAN REGION
Ministries of Health of the Americas pledge action to keep the region free of measles and rubella During the 29th Pan American Sanitary Conference, Ministers.
Presentation transcript:

The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012

Outline Country background information EPI Program Measles/rubella coverage and case reports Rubella outbreak CRS case reports measles/rubella campaign Way forward

Cape Verde: background Information 10 islands off the coast of West Africa Surface area: 4,030 Sq. KM Total population 2011 : 501,000 (UN Estimates) 61% urban Pop. <15 y: 155,000 Female 15-49: 135,000 GDP: 4123 US$

Overview of the EPI program – EPI program provides MCV1 at 9 months of age – Last case of polio in 2000 – Comprehensive measles elimination strategy implemented since 2002 – Reached and maintained high routine MCV1 coverage – Initiated rubella vaccination (MR) in routine EPI in 2010.

Routine Vaccine reported coverage, Cape Verde Reported MR vaccine admin coverage in 2011 = 99%

MCV1 coverage, measles and rubella cases reported in Cape Verde, a total of 21,000 cases reported : 9648 cases in 2008 and cases in 2009

Rubella outbreak in Cape verde: Attack rate by region

9 Meses – 15 Anos 9 Meses – 20 Anos

Documented rubella epidemic in Cape Verde – [N=9468] 57% female 11% 57% 24% 4%

Congenital rubella syndrome. Cape Verde, CRS cases reported in – 46 CRS cases documented in 2009 (JRF report) – 16 CRS cases documented in 2010 (JRF report) Cumulative incidence of 2.8/1,000 LB ~ 20 cases of severe ocular manifestations: – Pigmentary Retinopathy: 25%-50% – Cataract: 15% – Glaucoma: 10%

WHO Rubella position paper, July 2011 SAGE recommends that countries should take the opportunity of the two dose measles vaccine strategy to use MR or MMR vaccine. The preferred approach is to begin with MR vaccine or MMR vaccine in a wide-age range campaign followed immediately with introduction of MR, or MMR vaccine in the routine program.

Does Cape verde need to do MR SIAs? Does Cape verde need to do MR SIAs? Cape Verde introduced a routine dose of rubella containing vaccine at 15 months in 2010 Cape Verde did not conduct a mass rubella campaign Answer: Yes – Large proportion of susceptible children and young adults despite the outbreak – Global policy recommends a wide age range catch-up campaign (from 9m to 15 years or older) depending on the epidemiology of the country as part of elimination strategy

Rubella susceptibility in Cape Verde. The distribution of rubella cases: – high susceptibility between 13 and 17 years of age. Most mothers of CRS cases were years. – In 2013, this age group will be in the category 20 – 25 years.

Options for age groups to target in MR SIAs in 2013 Option 1: Vaccinate all children and young adults (9 months to 20 years). – This will leave an estimated immunity gap of 15 % for women and men older than 20 years. Option 2: Vaccinate all children 9 months– 18 years of age AND all women years of age (most will be bringing their children to the health post). – This strategy will leave an estimated immunity gap of 24 % among men older than 18 years, but less than 5% among women above 25 years of age Option 2 will have the largest impact on reducing future risk of CRS among the Cape Verde population. Option 2 will have the largest impact on reducing future risk of CRS among the Cape Verde population.

Way forward Develop a long term strategy for the elimination of rubella and CRS: – Catch-up SIAs, follow up SIAs every 4 years, maintain high MR coverage in Routine immunisation Implement the MR catch-up SIAs in 2013; – target population 9 mo – 20 yrs Strengthen the sensitivity and specificity of the disease surveillance system – Build capacity of clinicians to improve reporting

Obrigado Thank you Merci